Biaxin and Primary sequestrum - a phase IV clinical study of FDA data

Summary:

Primary sequestrum is reported as a side effect among people who take Biaxin (clarithromycin), especially for people who are female, 60+ old, also take Cipro, and have Metastases to bone.

The phase IV clinical study analyzes which people have Primary sequestrum when taking Biaxin. It is created by eHealthMe based on reports of 13,608 people who have side effects when taking Biaxin from the FDA, and is updated regularly.

What is Biaxin?

Biaxin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 14,248 Biaxin users. Check the latest studies of Biaxin.

What is Primary sequestrum?

Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone) is found to be associated with 598 drugs and 330 conditions by eHealthMe. Check the latest studies of Primary sequestrum.

On Jul, 19, 2026

13,608 people reported to have side effects when taking Biaxin.
Among them, 38 people (0.28%) have Primary sequestrum.

Among these 38 people:

What is the gender of people who have Primary sequestrum when taking Biaxin? *

female: 65.79 %
male: 34.21 %

What is the age of people who have Primary sequestrum when taking Biaxin? *

What are other drugs people take besides Biaxin? *

What are other side effects people have besides Primary sequestrum? *

Nausea And Vomiting: 37 people, 97.37%
Bone Disorder: 33 people, 86.84%
Osteonecrosis Of Jaw (death of bone of jaw): 32 people, 84.21%
Pain: 30 people, 78.95%
Stress And Anxiety: 30 people, 78.95%
Nausea (feeling of having an urge to vomit): 29 people, 76.32%
Pain In Jaw: 29 people, 76.32%
High Blood Pressure: 28 people, 73.68%
Neuropathy Peripheral (surface nerve damage): 28 people, 73.68%
Fatigue (feeling of tiredness): 27 people, 71.05%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 13 people, 34.21%
Prostate Cancer: 12 people, 31.58%
Multiple Myeloma (cancer of the plasma cells): 11 people, 28.95%
Pain: 8 people, 21.05%
Osteolysis (dissolution of bone): 5 people, 13.16%
Resorption Bone Increased: 4 people, 10.53%
Stress And Anxiety: 2 people, 5.26%
Thyroid Diseases: 1 person, 2.63%
Insomnia (sleeplessness): 1 person, 2.63%
High Blood Pressure: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Biaxin and have Primary sequestrum?

- Check whether Primary sequestrum is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biaxin:

Biaxin (14,248 reports)

Browse all side effects of Biaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Primary sequestrum:

Primary sequestrum (598 drugs)

Browse all the conditions that are associated with Primary sequestrum:

Primary sequestrum (330 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin (the active ingredients of Biaxin) and Biaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.